about
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in CancerTrichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis.Fasciola hepatica Immune Regulates CD11c+ Cells by Interacting with the Macrophage Gal/GalNAc Lectin.Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL.DCIR interacts with ligands from both endogenous and pathogenic origin.The Cholangiocyte Glycocalyx Stabilizes the 'Biliary HCO3 Umbrella': An Integrated Line of Defense against Toxic Bile Acids.A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.The Human Glycoprotein Salivary Agglutinin Inhibits the Interaction of DC-SIGN and Langerin with Oral Micro-Organisms.Using the glycan toolbox for pathogenic interventions and glycan immunotherapy.Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous CarcinomaIdentification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligandsBlocking α1-integrin reverts the adhesive phenotype of adult fibroblasts towards a foetal-like migratory phenotypeOncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N-acetylgalactosamine-transferase 3Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectinC-Mannosyl Lysine for Solid Phase Assembly of Mannosylated Peptide Conjugate Cancer VaccinesActivation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic CellsMethod comparison for N-glycan profiling: Towards the standardization of glycoanalytical technologies for cell line analysisGlycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia CellsSystematic Dual Targeting of Dendritic Cell C-Type Lectin Receptor DC-SIGN and TLR7 Using a Trifunctional Mannosylated AntigenCharacterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell linesThe Plasticity of the Carbohydrate Recognition Domain Dictates the Exquisite Mechanism of Binding of Human Macrophage Galactose-Type LectinGlycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor VaccinationMacrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammationTranscriptional activation of fucosyltransferase (FUT) genes using the CRISPR-dCas9-VPR technology reveals potent N-glycome alterations in colorectal cancer cells
P50
Q26751472-E02A305A-470A-40E1-95E1-BFBA3A4F7FADQ30658854-BD8172F1-E3BE-40E8-9445-2B4E19C2832AQ37699624-F01B4B34-A1D5-4AC2-9700-B57E2F3964C8Q38278143-814FA8A2-66FE-492E-BBD1-4A10B524ACCFQ38311185-EFBD1936-1C39-4465-81A0-BD87C0C7E95DQ38516765-0C057C03-4D1A-4535-ADF8-CF083D1FF015Q38751114-560E5818-5B15-426F-B978-54B6468F57AAQ39034129-1A12EF38-2390-43CC-8DF4-8F2081B09585Q40798161-F495B648-4328-42D0-9A9E-C726073391FAQ49630850-067FA347-9909-4B0B-9277-273772EEE52CQ55378528-3ABF9789-BD86-4232-B840-E786540C551CQ61807141-25EB8CE9-1C35-4568-9904-F5CCA47DF32AQ64166945-CA7FD6DB-C951-443C-931A-5D20E0313530Q87651873-442441E2-5634-4B2A-8A49-9B522C483904Q89077097-CE805C96-A5F3-4232-B487-F8339E184182Q89531656-D218A385-E037-4C74-8F32-088103C70C7BQ89654435-6ABC0803-16A9-4D8C-B3DA-89EF3F2C5FCDQ90248415-ABD88751-3372-4F77-B07D-5308C65F54E0Q90562178-80B05539-0314-497F-8D39-4A9B330F3AC6Q90737143-F80558B4-247F-4754-B1B8-BEDA752490DEQ90863915-8439F9AC-7DB9-4C3D-B55F-601F54D4795EQ92478222-08ABA369-6841-455C-B98D-2C5FFAD3FFEFQ92566719-164F5BB1-BA0E-4B7C-9C04-6C1735E7B18EQ92988727-B0488390-6E04-473D-A525-AE59B6139709Q93083704-CEB82A80-5ECB-4194-95F5-D9705743DB93Q93370073-7D5361CF-6F63-41E0-880F-775FAAC9ECE4
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sandra J van Vliet
@en
Sandra J van Vliet
@nl
type
label
Sandra J van Vliet
@en
Sandra J van Vliet
@nl
prefLabel
Sandra J van Vliet
@en
Sandra J van Vliet
@nl
P31
P496
0000-0003-1811-2687